MLH1 and MSH2 are most commonly associated with a higher risk of colorectal cancer.1 Additionally, MSH2 has been associated with a higher risk for extracolonic cancers, and female MSH6 carriers may have the highest risk of endometrial cancer. Here, MSH2 is linked to colorectal cancer.